Substituted pyridines as selective cyclooxygenase-2 inhibitors
申请人:Merck Frosst Canad, Inc.
公开号:US05861419A1
公开(公告)日:1999-01-19
The invention encompasses the novel compound of Formula I as well as a method of treating COX-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of COX-2 mediated diseases comprising compounds of Formula I.
[EN] PROCESS FOR MAKING 2-ARYL-3-ARYL-5-HALO PYRIDINES USEFUL AS COX-2 INHIBITORS<br/>[FR] PROCEDE DE FABRICATION DE 2-ARYL-3-ARYL-5-HALOPYRIDINES UTILES EN TANT QU'INHIBITEURS DE COX-2
申请人:MERCK & CO., INC.
公开号:WO1998047871A1
公开(公告)日:1998-10-29
(EN) The invention encompasses a process for making compounds of Formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases.(FR) L'invention concerne un procédé de fabrication de composés de formule (I), utiles dans le traitement de maladies induites par la cyclo-oxygénase-2.
该发明涵盖了一种制备式(I)化合物的过程,用于治疗环氧合酶-2介导的疾病。
PROCESS FOR MAKING 2-ARYL-3-ARYL-5-HALO PYRIDINES USEFUL AS COX-2 INHIBITORS